Journal details
JOURNAL FOR IMMUNOTHERAPY OF CANCER
BMJ PUBLISHING GROUP · eISSN 2051-1426
SCIEScopusMEDLINEPubMedPMCDOAJ
Overview
JOURNAL FOR IMMUNOTHERAPY OF CANCER. eISSN 2051-1426. published by BMJ PUBLISHING GROUP. England. Oncology · Immunology. impact factor 11.7 (2025). JCR Q1. CAS Zone 1 TOP. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 264 articles · 2025: 704 articles · 2024: 479 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of JOURNAL FOR IMMUNOTHERAPY OF CANCER?
The impact factor recorded for JOURNAL FOR IMMUNOTHERAPY OF CANCER is 11.7 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of JOURNAL FOR IMMUNOTHERAPY OF CANCER?
JOURNAL FOR IMMUNOTHERAPY OF CANCER is listed in CAS Zone 1 and marked as a TOP journal.
Which databases index JOURNAL FOR IMMUNOTHERAPY OF CANCER?
JOURNAL FOR IMMUNOTHERAPY OF CANCER is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Confirm on the journal website and the database itself before submitting.